论文部分内容阅读
近年的临床观察和研究发现,利血平为可疑致癌药物,长期应用可能诱发乳腺癌。绝经期妇女长期服用利血平,有增加乳腺癌发生的危险性,其发病率比未服此药的老年女性高3～4
Recent clinical observations and studies have shown that reserpine is a suspicious oncogenic drug and that long-term use may induce breast cancer. Long-term use of reserpine in menopausal women, have increased the risk of breast cancer, the incidence is higher than the elderly women did not take this drug 3 to 4